Close
4

Athena Athena

X

Find Milrinone manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

JP

0

Other Listed Suppliers

SERVICES

0

Looking for 78415-72-2 / Milrinone API manufacturers, exporters & distributors?

Milrinone manufacturers, exporters & distributors 1

18

PharmaCompass offers a list of Milrinone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Milrinone manufacturer or Milrinone supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Milrinone manufacturer or Milrinone supplier.

PharmaCompass also assists you with knowing the Milrinone API Price utilized in the formulation of products. Milrinone API Price is not always fixed or binding as the Milrinone Price is obtained through a variety of data sources. The Milrinone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Milrinone

Synonyms

78415-72-2, Primacor, Milrinona, Milrinonum, Milrila, 2-methyl-6-oxo-1,6-dihydro-[3,4'-bipyridine]-5-carbonitrile

Cas Number

78415-72-2

Unique Ingredient Identifier (UNII)

JU9YAX04C7

About Milrinone

A positive inotropic cardiotonic agent with vasodilator properties. It inhibits cAMP phosphodiesterase type 3 activity in myocardium and vascular smooth muscle. Milrinone is a derivative of amrinone and has 20-30 times the inotropic potency of amrinone.

1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile Manufacturers

A 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile, including repackagers and relabelers. The FDA regulates 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile Suppliers

A 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile supplier is an individual or a company that provides 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile active pharmaceutical ingredient (API) or 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile finished formulations upon request. The 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile suppliers may include 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile API manufacturers, exporters, distributors and traders.

click here to find a list of 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile USDMF

A 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile DMF (Drug Master File) is a document detailing the whole manufacturing process of 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile active pharmaceutical ingredient (API) in detail. Different forms of 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile DMFs exist exist since differing nations have different regulations, such as 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile DMF submitted to regulatory agencies in the US is known as a USDMF. 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile USDMF includes data on 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile suppliers with USDMF on PharmaCompass.

1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile Drug Master File in Japan (1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile JDMF) empowers 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile JDMF during the approval evaluation for pharmaceutical products. At the time of 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile suppliers with JDMF on PharmaCompass.

1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile suppliers with NDC on PharmaCompass.

1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile GMP

1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile GMP manufacturer or 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile GMP API supplier for your needs.

1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile CoA

A 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile CoA (Certificate of Analysis) is a formal document that attests to 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile's compliance with 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile specifications and serves as a tool for batch-level quality control.

1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile CoA mostly includes findings from lab analyses of a specific batch. For each 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile may be tested according to a variety of international standards, such as European Pharmacopoeia (1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile EP), 1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile JP (Japanese Pharmacopeia) and the US Pharmacopoeia (1,6-Dihydro-2-methyl-6-oxo-(3,4′-bipyridine)-5-carbonitrile USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY